ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.500,37
-0,54%
S&P 500
5.631,22
0,28%
Dow Jones
40.211,72
0,53%
Euro vs US Dollar
1,08967
-0,03%
Bitcoin
63.690,20
-1,81%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Opiant Pharmaceuticals Inc (OPNT)

  7. Opiant Pharmaceuticals Inc (OPNT) News

OPNT

Opiant Pharmaceuticals (OPNT)

Opiant Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OPNT
DatumZeitQuelleÜberschriftSymbolFirma
10/02/201118h12Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:OPNTOpiant Pharmaceuticals Inc
10/02/201112h00Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:OPNTOpiant Pharmaceuticals Inc
08/02/201122h05GlobeNewswire Inc.OPNET Introduces BTM Xpert(TM) - Solution for Business Transaction ManagementNASDAQ:OPNTOpiant Pharmaceuticals Inc
04/02/201122h09Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:OPNTOpiant Pharmaceuticals Inc
01/02/201120h02MarketwiredLightlake Therapeutics Takes Safer Approach to ObesityNASDAQ:OPNTOpiant Pharmaceuticals Inc
01/02/201119h22MarketwiredLightlake Therapeutics Takes Safer Approach to ObesityNASDAQ:OPNTOpiant Pharmaceuticals Inc
27/01/201122h10Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OPNTOpiant Pharmaceuticals Inc
27/01/201122h02GlobeNewswire Inc.OPNET Announces Record Financial Results for Third Quarter of Fiscal 2011NASDAQ:OPNTOpiant Pharmaceuticals Inc
13/01/201115h25GlobeNewswire Inc.OPNET Technologies, Inc. Schedules Fiscal Third Quarter Results Teleconference/Webcast for Thursday, January 27, 2011NASDAQ:OPNTOpiant Pharmaceuticals Inc
10/01/201121h58Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:OPNTOpiant Pharmaceuticals Inc
05/01/201122h05GlobeNewswire Inc.OPNET to Present at 13th Annual Needham Growth ConferenceNASDAQ:OPNTOpiant Pharmaceuticals Inc
05/01/201114h00GlobeNewswire Inc.OPNET Introduces AppMapper Xpert(TM) - SaaS-Based Offering for Application MappingNASDAQ:OPNTOpiant Pharmaceuticals Inc
29/12/201022h05GlobeNewswire Inc.OPNET Introduces Cloud Readiness Performance Assessment ServiceNASDAQ:OPNTOpiant Pharmaceuticals Inc
29/12/201015h15GlobeNewswire Inc.Lightlake Therapeutics, Inc Appoints Mary K Pendergast as Regulatory and Strategy AdvisorNASDAQ:OPNTOpiant Pharmaceuticals Inc
16/12/201016h33GlobeNewswire Inc.Lightlake Therapeutics, Inc. Acquires a Patent With the Potential to Establish a New Treatment Paradigm to Terminate Addiction tNASDAQ:OPNTOpiant Pharmaceuticals Inc
14/12/201020h17Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:OPNTOpiant Pharmaceuticals Inc
11/12/201000h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
10/12/201018h15Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/12/201000h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/12/201000h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/11/201015h10GlobeNewswire Inc.Lightlake Therapeutics, Inc. Secures Distinguished Executive as ChairmanNASDAQ:OPNTOpiant Pharmaceuticals Inc
20/11/201000h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
15/11/201019h46Edgar (US Regulatory)Annual Report (10-K)NASDAQ:OPNTOpiant Pharmaceuticals Inc
09/11/201018h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
09/11/201018h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
09/11/201017h58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
09/11/201017h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
05/11/201021h44Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:OPNTOpiant Pharmaceuticals Inc
04/11/201015h21GlobeNewswire Inc.OPNET to Present at TechAmerica 40th Annual AeA Classic Financial Conference in San Diego, CANASDAQ:OPNTOpiant Pharmaceuticals Inc
03/11/201021h46GlobeNewswire Inc.OPNET Announces Record Financial Results for Second Quarter of Fiscal 2011NASDAQ:OPNTOpiant Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:OPNT

Kürzlich von Ihnen besucht

TG
RHM
Rheinmetall
CCOM
US500
US 500
CCOM
US30
US 30
NASDAQ
GOOGL
Alphabet
AMEX
XLE
Energy Select Sector SPDR
NYSE
JPM
JP Morgan Chase
USOTC
BASFY
BASF (QX)
DBI
MDAX
MDAX
NYSE
KO
Coca Cola
AMEX
SPY
SPDR S&P 500
TG
LHA
Deutsche Lufthansa
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLV
Health Care Select Sector
TG
DBK
Deutsche Bank
COIN
ETHUSD
Ethereum
TG
432
Arbor Metals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten